Antibody evasion by the P.1 strain of SARS-CoV-2
Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates. However, new strains have emerged with multiple mutations, including P.1 from Brazil, B.1.351 from South Africa, and B.1.1.7...
Үндсэн зохиолчид: | Dejnirattisai, W, Zhou, D, Supasa, P, Liu, C, Mentzer, AJ, Ginn, HM, Zhao, Y, Duyvesteyn, HME, Tuekprakhon, A, Nutalai, R, Wang, B, López-Camacho, C, Slon-Campos, J, Walter, TS, Skelly, D, Costa Clemens, SA, Naveca, FG, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Dold, C, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Crook, D, Lambe, T, Clutterbuck, E, Bibi, S, Flaxman, A, Bittaye, M, Belij-Rammerstorfer, S, Gilbert, SC, Carroll, MW, Klenerman, P, Barnes, E, Dunachie, SJ, Paterson, NG, Williams, MA, Hall, DR, Hulswit, RJG, Bowden, TA, Fry, EE, Mongkolsapaya, J, Ren, J, Stuart, DI, Screaton, GR |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Cell Press
2021
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
-н: Zhou, D, зэрэг
Хэвлэсэн: (2021) -
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
-н: Liu, C, зэрэг
Хэвлэсэн: (2021) -
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
-н: Supasa, P, зэрэг
Хэвлэсэн: (2021) -
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
-н: Nutalai, R, зэрэг
Хэвлэсэн: (2022) -
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
-н: Liu, C, зэрэг
Хэвлэсэн: (2021)